New Arknights: Prelude to Dawn Anime Trailer Revealed

Arknights: Prelude to Dawn Trailer

Yostar and Hypergryph conducted the 2.5 year anniversary stream for the global edition of Arknights on July 23, 2022. Alongside previews of the upcoming anniversary event, a new trailer for Arknights: Prelude to Dawn, the anime adaptation of the game, was shown.

The trailer features new footage from the show, as well as voice acting in Japanese by Tomoyo Kurosawa, who plays Amiya.

The setting and catalyst for events in the game world of Terra is clarified a bit more in the traile for Arknights: Prelude to Dawn. Amiya’s speech reveals that Originium, the fictional material that powers all manner of technology and Arts (magic) in Arknights‘ world is also the source of Oripathy. Oripathy is an incurable disease caused by exposure to Originium. While some gain unusual powers and abilities due to their Oripathy symptoms, most “Infected” are doomed to a painful existence. Infected sometimes form Originium crystals on their skin or organs, and even explode when they die. Infected are segregated away by various Terran governments and persecuted mercilessly.

Rhodes Island, Amiya’s and the player’s organization, is a pharmaceutical company/paramilitary outfit researching cures for Oripathy and advocating for better treatment of Infected. As seen in the Arknights: Prelude to Dawn trailer, their opponent is Reunion. Reunion is an organization made up of Infected, waging armed insurgency against Terran governments in the name of the Infected. Reunion Commanders like Mephisto and Crownslayer are visible in the trailer.

Arknights: Prelude to Dawn is in production, though does not have a premiere window. The game is available on iOS and Android. Check out the previous trailer for the anime.

Josh Tolentino
About The Author
Josh Tolentino is Senior Staff Writer at Siliconera. He previously helped run Japanator, prior to its merger with Siliconera. He's also got bylines at Destructoid, GameCritics, The Escapist, and far too many posts on Twitter.